Anne Martin-Salazar

Anne Martin-Salazar

Auto-generated profile, based on publicly available information

Anne Martin-Salazar

Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
EVElena Ethel Vidal-Calvo
Elena Ethel Vidal-Calvo
AMAnne Martin-Salazar
Anne Martin-Salazar
SCSwati Choudhary
Swati Choudhary
RDRobert Dagil
Robert Dagil
SRSai Sundar Rajan Raghavan
Sai Sundar Rajan Raghavan
ASAli salanti
Ali salanti
Molecular similarities between embryonic and malignant cells can be exploited to target tumors through specific signatures absent in healthy adult tissues. One such embryonic signature tumors express is oncofetal chondroitin sulfate (ofCS), which supports disease progression and dissemination in cancer. Here, we report the identification and characterization of phage display-derived antibody fragments recognizing two distinct ofCS epitopes. These antibody fragments show binding affinity to ofCS in the low nanomolar range across a broad selection of solid tumor types in vitro and in vivo with minimal binding to normal, inflamed, or benign tumor tissues. Anti-ofCS antibody drug conjugates and bispecific immune cell engagers based on these targeting moieties disrupt tumor progression in animal models of human and murine cancers. Thus, anti-ofCS antibody fragments hold promise for the development of broadly effective therapeutic and diagnostic applications targeting human malignancies.